Showing results (101-110 of 297) with videos related to
Sort By:
Pageof 30
Chinese Clinical Oncology|September 14, 2020
Germline mutations and prostate cancer: is it time to change treatment algorithms?Talar Telvizian, Deborah MukherjiExpert Opinion on Pharmacotherapy|June 24, 2010
Pixantrone for the treatment of aggressive non-Hodgkin lymphomaDeborah Mukherji, Ruth PettengellExpert Opinion on Drug Discovery|March 14, 2013
A review of in vitro and in vivo models of oesophageal and gastric cancerDeborah Mukherji, Tim BenepalExpert Opinion on Investigational Drugs|February 27, 2009
Second-generation epidermal growth factor tyrosine kinase inhibitors in non-small cell lung cancerDeborah Mukherji, James SpicerDrugs of Today (Barcelona, Spain : 1998)|February 4, 2010
Pixantrone maleate for non-Hodgkin's lymphomaDeborah Mukherji, Ruth PettengellThrombosis Journal|July 11, 2018
Could sodium imbalances predispose to postoperative venous thromboembolism? An analysis of the NSQIP databaseSally Temraz, Hani Tamim, Aurelie Mailhac, et al.Expert Review of Hematology|October 3, 2013
Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemiaAli T Taher, Sally Temraz, M Domenica CappelliniBMJ Case Reports|February 26, 2013
Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patientOla Abbas, Ali Shamseddin, Sally Temraz, et al.Radiation Oncology (London, England)|October 8, 2020
Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinomaAli Shamseddine, Youssef H Zeidan, Ziad El Husseini, et al.World Journal of Surgical Oncology|June 8, 2013
Postoperative outcomes following pancreaticoduodenectomy: how should age affect clinical practice?Walid Faraj, Raafat Alameddine, Deborah Mukherji, et al.Pageof 30